Non‐small cell lung cancer in China

• Published in: Cancer communications (London, England) Vol. 42; no. 10; pp. 937 - 970
• Main Authors: Chen, Peixin, Liu, Yunhuan, Wen, Yaokai, Zhou, Caicun
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.10.2022; John Wiley and Sons Inc; Wiley
• Subjects: Age; B7-H1 Antigen - metabolism; Carcinoma, Non-Small-Cell Lung - epidemiology; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - therapy; Cell death; Chemotherapy; Chronic obstructive pulmonary disease; clinical guidelines; Clinical practice guidelines; clinical trials; Epidermal growth factor; epidermal growth factor receptor (EGFR) mutation; Health risks; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Kinases; Lung cancer; Lung Neoplasms - epidemiology; Lung Neoplasms - genetics; Lung Neoplasms - therapy; Lymphoma; Males; Medical screening; Mortality; Mutation; non‐small cell lung cancer; Pathology; Programmed Cell Death 1 Receptor - metabolism; programmed cell death protein 1 (PD‐1); programmed death‐ligand 1 (PD‐L1); Radiation therapy; Review; Reviews; Sarcoma; Science education; screening; targeted therapy; Tomography; United States > US; China; non-small cell lung cancer; targeted therapy; screening; clinical guidelines; programmed death-ligand 1 (PD-L1); immunotherapy; clinical trials; programmed cell death protein 1 (PD-1); epidermal growth factor receptor (EGFR) mutation

In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors for lung cancer include tobacco use, family history, radiation exposure, and the presence of chronic lung diseases. Most early‐stage non‐small cell lung cancer (NSCLC) patients miss the optimal timing for...